Use access key #2 to skip to page content.
$9.69 -0.81 (-7.71%)
10/6/2008 4:02 PM

Elan Corp, plc (ADR) (ELN)

CAPS Rating:
***

The Company's Biopharmaceuticals unit is engaged in research, development and commercial activities and its EDT unit focuses on product development, scale-up and manufacturing to address drug optimization challenges of the pharmaceutical industry.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ELN

Add Stock to Watchlist

What the Community Thinks

Total Members

764 Outperforms
66 Underperforms
 

All-Stars

113 Outperforms
25 Underperforms
 

Wall Street

2 Outperforms
5 Underperforms
 

Members bullish on ELN are also bullish on:

Members bearish on ELN are also bearish on:

Ticker Tags

Ireland (10), Biotechnology (295), Nanotechnology (29), Large Cap (467), Dublin (6), Neuroscience (8), Mid Cap (670), Rule Breakers Universe (161), Drug Delivery (22)
Suggest a tag

Elan Corp, plc (ADR) At A Glance

Current Price: $9.69
Last Trade Time: 10/6/2008 4:02 PM
Open: $10.00
Previous Close: $10.50
Daily Range: $8.84 - $10.07
52-Week Range: $9.55 - $37.45
Volume: 6,139,567
Market Cap: $5.30B
P/E Ratio: 0.00
Compare Our Special Broker Offers!

Stock Trends

ELN VS S&P 500 (SPY)

ELN 12 month chart vs. S&P

News & Discussion Boards

Top Bull Pitch

Recs

3

Elan Corp, plc (ADR) (ELN)

Avatar BeautifulPlumage (99.96) Submitted: 7/30/08 3:02 PM

The stock was a little overpriced, but a 40% drop on OK news from its phase 2 trial for bapineuzumab puts it right back in the 'reasonably valued' class, and although the chances of gigantic success from bap have taken a baby step backwards, there is stille lots to look forward to, including nataliz...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

1

Elan Corp, plc (ADR) (ELN)

Avatar morningstarboy (80.89) Submitted: 2/21/08 1:04 PM

As of close of business on 2/20/08, this was a 1-star Morningstar stock trading at more than double its Morningstar fair value.

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 200 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (ELN)

Avatar JVH1 (< 20) Submitted: 10/06/08 12:35 PM : Outperform Start Price: $9.48 ELN Score: 1.15

i AM VERY SMART. i KNOW ELAN'S PROBLEMS AND WHAT THEY HAVE TO OFFER REGARDING PHARM AND BRAIN SCIENCES. i UNFORTUNATLEY KNOW WHERE THE REST OF THE MARKET IS AT AND THE S&P TOO. NOT TO SAY STANDARD AND POOR IS LESSER FOR SURE. JUST ONE PHARM COMPANY HERE I AM SPEAKING OF AMIDST MANY OTHERS TOO. JVH1

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ELN)

Avatar SimpleSimonSaid (< 20) Submitted: 9/21/08 4:21 PM : Outperform Start Price: $11.67 ELN Score: -1.02

Tysabri and Alzheimers pipeline.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ELN)

Avatar stockdoc00 (90.04) Submitted: 9/14/08 8:51 PM : Outperform Start Price: $11.12 ELN Score: 4.09

A high risk high reward company with a very promising pipeline, in particular for Alzheimer's and multiple sclerosis. The recent Tysabri scare that precipitated its sudden drop was a huge overreaction by the investor community. While its fundamentals are not up to par compared with other premier pharma co's, it is way oversold and a great buy at its current levels.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ELN)

Avatar tz7bandit (62.95) Submitted: 9/11/08 5:29 PM : Outperform Start Price: $12.66 ELN Score: -8.36

I like risk...thanks for putting this on sale for me MR market me and Kam are gonna get rich on this one baby

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ELN)

Avatar indyjoneses (99.85) Submitted: 8/28/08 12:11 PM : Outperform Start Price: $13.55 ELN Score: -9.13

Just like BIIB, I think the most recent Market reaction is an overreaction... FDA seems happy with the way BIIB & ELN are handling the Tysabri issue, and bottom line, a lot of MS patients are benefitting, and are willing to try the drug...

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 200 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 7 of 7  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackBreanMurray 91.75 07/11/08 Underperform NS $34.91-72.24%-15.21%+57.03
TrackPiperJaff 71.77 07/11/08 Underperform NS $34.91-72.24%-15.21%+57.03
TrackMerrimanCo < 20 06/11/08 Outperform NS $26.33-63.20%-23.25%-39.94
TrackCarisandCo 74.89 05/15/08 Underperform NS $27.10-64.24%-25.83%+38.42
TrackCanaccord < 20 03/26/08 Underperform NS $20.78-53.37%-22.07%+31.30
TrackEdwardOwens 99.57 09/30/07 Outperform NS $21.04-53.94%-31.37%-22.58 Toggle the visibility of 60-Second Pitch and replies
TrackJimCramer 82.79 08/28/07 Underperform 3W $18.86-48.62%-27.14%+21.49

Results 1 - 7 of 7  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

EQWEB20 875ms